accountrecent U.S. sales-force cuts, the loss of a key delivery catheter and regulatory tangles. Rising competition from Abbott Laboratories (NYSE:ABT) Overall, Cordis sales cover a fast-growing business for treating a common rhythm disorder, but they still...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to J&J's stent business struggles persist
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account